Fecal microbiota transplantation in cats with recurrent and chronic giardiasis: targeted therapy

Kerem Ural

Makale detayları

Fecal microbiota transplantation in cats with recurrent and chronic giardiasis: targeted therapy

Yazarlar:

Kerem Ural

Yayıncı:

Yozgat Bozok University

Ana Başlıklar:

Veteriner İç Hastalıkları

Dergi:

Bozok Veterinary Sciences Vol.6 Issue 1, pp.1-7

Belge Tipi:

Makale

Yayın Tarihi:

6/2025

Belge Dili:

Türkçe

Document ID (Org No.):

2001350607

pISSN:

2757-5179

Anahtar kelimeler:

Özet:

 Giardiasis poses a significant health risk for both humans and animals. There are limited treatment options for feline giardiasis, which has the risk of harboring zoonotic Giardia species. The present study aims to provide a possible natural and complete treatment for recurrent and chronic giardiasis patients in cats with fecal microbiota transplantation fmt. For this purpose, improved diagnostic utility with G. duodenalis fecal antigens immunochromatographic, fecal cyststrophozoites microscopically by flotation and polymerase chain reaction was assumed to be present throughout the study. This study covers a 10-year period between 2014 and 2024 and aims to determine the efficacy of fecal microbiota transplantation fmt in cats with giardiasis. Chronic giardiasis was diagnosed in 11 cats included in the study with relevant diagnostic tests. Appropriate fmt was applied 1-3 times on a case-by-case basis. While cyst scores varied between 2-4 before treatment the highest cyst score was 4 in 4 cases, in the comparative evaluation after treatment with fmt, they were between 0 and 2 3 out of 4 cases with the highest cyst score were 1 and 1 was 0. Cyst scores after fmt were 0 in 7 out of 11 cases. The statistical difference p0.005 between the median value 3.0 and the median value 1.0 after fmt in the scores regarding cyst counts at the beginning of the study can be associated with the success of treatment.

 Giardiasis poses a significant health risk for both humans and animals. There are limited treatment options for feline giardiasis, which has the risk of harboring zoonotic Giardia species. The present study aims to provide a possible natural and complete treatment for recurrent and chronic giardiasis patients in cats with fecal microbiota transplantation fmt. For this purpose, improved diagnostic utility with G. duodenalis fecal antigens immunochromatographic, fecal cyststrophozoites microscopically by flotation and polymerase chain reaction was assumed to be present throughout the study. This study covers a 10-year period between 2014 and 2024 and aims to determine the efficacy of fecal microbiota transplantation fmt in cats with giardiasis. Chronic giardiasis was diagnosed in 11 cats included in the study with relevant diagnostic tests. Appropriate fmt was applied 1-3 times on a case-by-case basis. While cyst scores varied between 2-4 before treatment the highest cyst score was 4 in 4 cases, in the comparative evaluation after treatment with fmt, they were between 0 and 2 3 out of 4 cases with the highest cyst score were 1 and 1 was 0. Cyst scores after fmt were 0 in 7 out of 11 cases. The statistical difference p0.005 between the median value 3.0 and the median value 1.0 after fmt in the scores regarding cyst counts at the beginning of the study can be associated with the success of treatment.

 Giardiasis poses a significant health risk for both humans and animals. There are limited treatment options for feline giardiasis, which has the risk of harboring zoonotic Giardia species. The present study aims to provide a possible natural and complete treatment for recurrent and chronic giardiasis patients in cats with fecal microbiota transplantation fmt. For this purpose, improved diagnostic utility with G. duodenalis fecal antigens immunochromatographic, fecal cyststrophozoites microscopically by flotation and polymerase chain reaction was assumed to be present throughout the study. This study covers a 10-year period between 2014 and 2024 and aims to determine the efficacy of fecal microbiota transplantation fmt in cats with giardiasis. Chronic giardiasis was diagnosed in 11 cats included in the study with relevant diagnostic tests. Appropriate fmt was applied 1-3 times on a case-by-case basis. While cyst scores varied between 2-4 before treatment the highest cyst score was 4 in 4 cases, in the comparative evaluation after treatment with fmt, they were between 0 and 2 3 out of 4 cases with the highest cyst score were 1 and 1 was 0. Cyst scores after fmt were 0 in 7 out of 11 cases. The statistical difference p0.005 between the median value 3.0 and the median value 1.0 after fmt in the scores regarding cyst counts at the beginning of the study can be associated with the success of treatment.

 Giardiasis hem insanlar hem de hayvanlar için önemli ölçüde sağlık açısından tehlikeli bir sorun teşkil eder. Zoonotik Giardia türlerine ev sahipliği yapma riski bulunan kedi giardiasisi için sınırlı tedavi seçenekleri vardır. Mevcut çalışma, kedilerde tekrarlayan ve kronik giardiasis hastalarına dışkı mikrobiyotası nakli fmt ile olası doğal ve tam bir tedavi sağlamayı amaçlamaktadır. Bu amaçla, G. duodenalis dışkı antijenleri immünokromatografik, dışkı kistitrofozoitleri mikroskopik olarak flotasyon yoluyla ve polimeraz zincir reaksiyonu ile gelişmiş tanısal fayda tüm çalışma boyunca mevcut kabul edilmiştir. Bu çalışma 2014-2024 yılları arasında 10 yıllık dönemi kapsamakta olup, giardiasisli kedilerde fekal mikrobiyota transplantasyonunun fmt etkinliğini saptanması amaçlanmıştır. Çalışmaya dahil edilen 11 kedide ilişkili tanısal testlerle kronikleşen giardiasis tanısı konuldu. Usülüne uygun fmt olgu bazında 1-3 kez uygulandıç Kist skorları sağaltım öncesi 2-4 arasında değişirken 4 olguda en yüksek kist skoru olan 4 puan tespit edildi, fmt ile sağaltım sonrası mukayeseli değerlendirmede 0 ile 2 arasında en yüksek kist skoruna sahip 4 olgundan 3ünde 1, 1inde 0 olarak saptandı. Onbir olgunun 7sinde fmt sonrası kist skorları 0 idi. Çalışma başlangıcında kist sayımlarına ilişkin skorlamalarda ortanca değer 3.0 ile fmt sonrası ortanca değer 1.0 arası istatsitiksel farklılığın p0.005 bulunması sağaltım başarısı ile ilişkilendirilebilinir.

Makale detayları

Fecal microbiota transplantation in cats with recurrent and chronic giardiasis: targeted therapy

Yazarlar:

Kerem Ural

Yayıncı:

Yozgat Bozok University

Ana Başlıklar:

Veteriner İç Hastalıkları

Dergi:

Bozok Veterinary Sciences Vol.6 Issue 1, pp.1-7

Belge Tipi:

Makale

Yayın Tarihi:

6/2025

Belge Dili:

Türkçe

Document ID (Org No.):

2001350607

pISSN:

2757-5179

cat

chronic

giardiasis

fecal microbiata transplantationgiardiasis

fekal mikrobiyota transplantasyonu

kedi

kronik

Sayı

Makale detayları

Yazarlar: Kerem Ural

Yayıncı: Yozgat Bozok University

Ana Başlıklar: Veteriner İç Hastalıkları

Dergi: Bozok Veterinary Sciences Vol.6 Issue 1, pp.1-7

Belge Tipi: Makale

Yayın Tarihi: 6/2025

Belge Dili: Türkçe

Document ID (Org No.): 2001350607

pISSN: 2757-5179

Sayı

Yazarlar:

Kerem Ural

Yayıncı:

Yozgat Bozok University

Ana Başlıklar:

Veteriner İç Hastalıkları

Dergi:

Bozok Veterinary Sciences Vol.6 Issue 1, pp.1-7

Belge Tipi:

Makale

Yayın Tarihi:

6/2025

Belge Dili:

Türkçe

Document ID (Org No.):

2001350607

pISSN:

2757-5179